Tactile Medical
TCMDPrivate Company
Total funding raised: $125M
Overview
Tactile Medical is a commercial-stage, publicly-traded medical device company with a mission to reveal and treat underserved chronic conditions, enabling at-home self-care. The company has established a strong commercial footprint in the US, driven by its flagship Flexitouch and next-generation Nimbl pneumatic compression systems for lymphedema, supported by a robust body of clinical evidence and a direct-to-patient commercial model. Its strategy focuses on expanding awareness, improving patient access, and innovating its product portfolio to drive growth in its core markets while exploring new indications.
Technology Platform
Platform centered on advanced pneumatic compression devices (Flexitouch, Nimbl) for lymphatic stimulation and High Frequency Chest Wall Oscillation (AffloVest) for airway clearance, designed for at-home patient use.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes with other pneumatic compression device makers (e.g., Lympha Press, Bio Compression) and respiratory vest providers. Differentiation is achieved through strong clinical evidence, a focus on mimicking manual lymphatic drainage, and a comprehensive commercial support model.
Company Timeline
Founded in Minneapolis, United States
IPO — $75.0M
Debt: $50.0M